Clinical Application of Pharmacogenomics in Oncology, Adverse Reactions and Electronic Health Records
Kristine R. Crews, Pharm. D.
Translational Research Laboratory Director
Co-director, Pharmacokinetics Shared Resource
Director, PGY2 Pharmacogenetics Residency Program
J. Kevin Hicks, Pharm.D, Ph.D.
Personalized Medicine Specialist, Department of Individualized Cancer Management
Moffitt Cancer Center
Assistant Professor, Morsani College of Medicine
University of South Florida
ACPE University Activity Number
01/01/2018 – 01/01/2021
This course will summarize pharmacogenomics in oncology, adverse reactions, and electronic health records.
Clinical Applications in Oncology Pharmacogenetics
- Describe clinical implications of genetic variability in oncology pharmacotherapy.
- Discuss clinical, patient-specific, genetic, and other factors that inform drug therapy changes in oncology.
- Summarize the structure and characteristics of reprentative oncology pharmacogenetics implementations.
Clinical Applications of Pharmacogenetics in Hypersensitivity/Adverse Drug Reactions
- Discuss the mechanism of drug-induced hypersensitivity.
- Summarize the evidence and discuss clinical implications for the association of HLA-B and HLA-A with carbamazepine-induced hypersensitivty reactions.
- Summarize the evidence and discuss clinical implications for the association of HLA-B with abacavir-induced hypersensitive reactions.
- Summarize the evidence and discuss clinical implications for the association of HLA-B with allopurinol-induced hypersensitive reactions.
Schedule of Activities
View the recorded lectures and complete the post-test.
Requirements for Successful Course Completion
View recorded lectures, receive a 70% or higher on final exam and complete course evaluation.
Program Financial Support
This course received no outside funding support.
Acknowledgement and Disclosures
Kristine R. Crews, Pharm. D. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
J. Kevin Hicks, Pharm.D, Ph.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose
Computer and Internet access are required to complete this course. Course content is provided via Canvas.
The minimum hardware, software, and Internet requirements for Canvas can be found here.
This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.
For questions or more information, please contact our office.
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.